• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负鼠(弗吉尼亚负鼠)和人类红细胞中高铁血红蛋白形成与还原的比较研究

Comparative aspects of methemoglobin formation and reduction in opossum (Didelphis virginiana) and human erythrocytes.

作者信息

Bethlenfalvay N C, Waterman M R, Lima J E, Waldrup T

出版信息

Comp Biochem Physiol A Comp Physiol. 1983;75(4):635-9. doi: 10.1016/0300-9629(83)90433-4.

DOI:10.1016/0300-9629(83)90433-4
PMID:6137318
Abstract

Glucose-depleted, nitrite-treated opossum erythrocytes effectively reduce methemoglobin in an environment of physiological saline and added glucose does not accelerate the rate of reduction. In autologous plasma or 25 mM phosphate-buffered saline pH 7.4, added glucose significantly accelerates methemoglobin reduction in glucose-depleted, nitrite-treated opossum erythrocytes. Human red cells require added glucose to carry out reduction of methemoglobin and increased phosphate concentration or autologous plasma does not alter the rate of this process. Within the opossum red cell in vitro, autooxidation of hemoglobin proceeds at a much slower rate than that observed in human erythrocytes.

摘要

葡萄糖耗尽、经亚硝酸盐处理的负鼠红细胞在生理盐水环境中能有效还原高铁血红蛋白,添加葡萄糖并不会加快还原速率。在自体血浆或pH 7.4的25 mM磷酸盐缓冲盐水中,添加葡萄糖能显著加快葡萄糖耗尽、经亚硝酸盐处理的负鼠红细胞中高铁血红蛋白的还原。人类红细胞需要添加葡萄糖才能还原高铁血红蛋白,增加磷酸盐浓度或自体血浆并不会改变这一过程的速率。在体外负鼠红细胞内,血红蛋白的自动氧化速率比在人类红细胞中观察到的要慢得多。

相似文献

1
Comparative aspects of methemoglobin formation and reduction in opossum (Didelphis virginiana) and human erythrocytes.负鼠(弗吉尼亚负鼠)和人类红细胞中高铁血红蛋白形成与还原的比较研究
Comp Biochem Physiol A Comp Physiol. 1983;75(4):635-9. doi: 10.1016/0300-9629(83)90433-4.
2
Studies on the energy metabolism of opossum Didelphis virginiana erythrocytes--III. Metabolic depletion with 2-deoxyglucose markedly accelerates methemoglobin reduction in opossum but not in human erythrocytes.负鼠弗吉尼亚负鼠红细胞能量代谢的研究——III. 2-脱氧葡萄糖导致的代谢耗竭显著加速负鼠而非人类红细胞中高铁血红蛋白的还原。
Comp Biochem Physiol A Comp Physiol. 1988;89(2):119-24. doi: 10.1016/0300-9629(88)91067-5.
3
Studies on the energy metabolism of opossum Didelphis virginiana erythrocytes--II. Comparative aspects of 2-deoxy-D-glucose catabolism in opossum and human red cells in vitro.负鼠(弗吉尼亚负鼠)红细胞能量代谢的研究——II. 负鼠和人类红细胞体外2-脱氧-D-葡萄糖分解代谢的比较方面
Comp Biochem Physiol A Comp Physiol. 1988;89(2):113-7. doi: 10.1016/0300-9629(88)91066-3.
4
Methemoglobin formation and reduction in canine erythrocytes with inherited high Na,K-ATPase activity.遗传性高钠钾-ATP酶活性犬红细胞中高铁血红蛋白的形成与还原
Nihon Juigaku Zasshi. 1989 Dec;51(6):1185-92. doi: 10.1292/jvms1939.51.1185.
5
Oxidation reactions of human, opossum (Didelphis virginiana) and spot (Leiostomus xanthurus) hemoglobins: a search for a correlation with some structural-functional properties.人类、负鼠(弗吉尼亚负鼠)和斑点原鮨血红蛋白的氧化反应:探寻与某些结构功能特性的相关性。
Comp Biochem Physiol B. 1993 Oct;106(2):427-32. doi: 10.1016/0305-0491(93)90324-x.
6
2'-Deoxyadenosine metabolism in human and opossum Didelphis virginiana erythrocytes in vitro.
Comp Biochem Physiol B. 1993 Nov;106(3):641-5. doi: 10.1016/0305-0491(93)90142-r.
7
Oxidation-reduction properties of the hemoglobin of the opossum, Didelphis virginiana.
Comp Biochem Physiol B. 1982;73(3):585-90. doi: 10.1016/0305-0491(82)90079-7.
8
Proposed mechanism of nitrite-induced methemoglobinemia.亚硝酸盐诱导高铁血红蛋白血症的潜在机制。
Biochemistry (Mosc). 2005 Apr;70(4):473-83. doi: 10.1007/s10541-005-0139-7.
9
Studies on the energy metabolism of opossum (Didelphis virginiana) erythrocytes: V. Utilization of hypoxanthine for the synthesis of adenine and guanine nucleotides in vitro.
J Cell Physiol. 1990 Jun;143(3):563-8. doi: 10.1002/jcp.1041430322.
10
The effect of ascorbic acid on nitrite-induced methemoglobin formation in rats, sheep, and normal human erythrocytes.
Regul Toxicol Pharmacol. 1983 Sep;3(3):184-8. doi: 10.1016/0273-2300(83)90026-0.